498 related articles for article (PubMed ID: 26243012)
61. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ
Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
[TBL] [Abstract][Full Text] [Related]
62. Old and new immunohistochemical markers for the diagnosis of gastrointestinal stromal tumors.
González-Cámpora R; Delgado MD; Amate AH; Gallardo SP; León MS; Beltrán AL
Anal Quant Cytol Histol; 2011 Feb; 33(1):1-11. PubMed ID: 22125840
[TBL] [Abstract][Full Text] [Related]
63. Biological and clinical review of stromal tumors in the gastrointestinal tract.
Nishida T; Hirota S
Histol Histopathol; 2000 Oct; 15(4):1293-301. PubMed ID: 11005253
[TBL] [Abstract][Full Text] [Related]
64. Leiomyoma of the gastrointestinal tract with interstitial cells of Cajal: a mimic of gastrointestinal stromal tumor.
Deshpande A; Nelson D; Corless CL; Deshpande V; O'Brien MJ
Am J Surg Pathol; 2014 Jan; 38(1):72-7. PubMed ID: 24145645
[TBL] [Abstract][Full Text] [Related]
65. [CD117 contribution in the diagnosic of mesenchymal tumors of the digestive tract].
Khadija B; Saadia B; Ines C; Sami K; Mohamed J; Zina C; Nidhammeddine K; Mohamed MZ; Slim H
Tunis Med; 2005 Nov; 83(11):669-71. PubMed ID: 16422363
[TBL] [Abstract][Full Text] [Related]
66. Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.
Jasek K; Buzalkova V; Minarik G; Stanclova A; Szepe P; Plank L; Lasabova Z
Virchows Arch; 2017 Jan; 470(1):29-36. PubMed ID: 27864688
[TBL] [Abstract][Full Text] [Related]
67. GEIS guidelines for gastrointestinal sarcomas (GIST).
Poveda A; García Del Muro X; López-Guerrero JA; Cubedo R; Martínez V; Romero I; Serrano C; Valverde C; Martín-Broto J;
Cancer Treat Rev; 2017 Apr; 55():107-119. PubMed ID: 28351781
[TBL] [Abstract][Full Text] [Related]
68. [Gastrointestinal stromal tumors (GISTs): clinical and pathological features].
Kovács M; Nagy P; Pák G; Fehér J
Orv Hetil; 2005 Jun; 146(26):1375-81. PubMed ID: 16052979
[TBL] [Abstract][Full Text] [Related]
69. Functional role of the Ca²⁺-activated Cl⁻ channel DOG1/TMEM16A in gastrointestinal stromal tumor cells.
Berglund E; Akcakaya P; Berglund D; Karlsson F; Vukojević V; Lee L; Bogdanović D; Lui WO; Larsson C; Zedenius J; Fröbom R; Bränström R
Exp Cell Res; 2014 Aug; 326(2):315-25. PubMed ID: 24825187
[TBL] [Abstract][Full Text] [Related]
70. [Expression and gene mutation of phospho-platelet derived growth factor receptor alpha and C-kit in gastrointestinal and extra-gastrointestinal stromal tumors].
Tang M; Li DQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):80-3. PubMed ID: 18197502
[TBL] [Abstract][Full Text] [Related]
71. Discovered on gastrointestinal stromal tumor 1, a keystone in the diagnosis of extraintestinal gastrointestinal stromal tumors.
Sahu KK; Tapadia R; Kini JR; Pai RR; Kini H; Nirupama M; Pooja KS
J Cancer Res Ther; 2019; 15(1):138-141. PubMed ID: 30880769
[TBL] [Abstract][Full Text] [Related]
72. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.
Kim WK; Park M; Kim YK; Tae YK; Yang HK; Lee JM; Kim H
Clin Cancer Res; 2011 Dec; 17(24):7584-94. PubMed ID: 22042971
[TBL] [Abstract][Full Text] [Related]
73. A KIT-negative, DOG1-positive epithelioid GIST of the stomach harboring a novel PDGFRA exon 14 single nucleotide deletion.
Rizzardi C; Marzinotto S; Avellini C; Melato M; Mariuzzi L
Anticancer Res; 2012 May; 32(5):1775-8. PubMed ID: 22593460
[TBL] [Abstract][Full Text] [Related]
74. Anti-tumor effects of the Notch pathway in gastrointestinal stromal tumors.
Dumont AG; Yang Y; Reynoso D; Katz D; Trent JC; Hughes DP
Carcinogenesis; 2012 Sep; 33(9):1674-83. PubMed ID: 22764137
[TBL] [Abstract][Full Text] [Related]
75. ETV1-Positive Cells Give Rise to
Ran L; Murphy D; Sher J; Cao Z; Wang S; Walczak E; Guan Y; Xie Y; Shukla S; Zhan Y; Antonescu CR; Chen Y; Chi P
Cancer Res; 2017 Jul; 77(14):3758-3765. PubMed ID: 28539323
[TBL] [Abstract][Full Text] [Related]
76. Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.
Miettinen M; Lasota J
Virchows Arch; 2001 Jan; 438(1):1-12. PubMed ID: 11213830
[TBL] [Abstract][Full Text] [Related]
77. Clinicopathological characteristics of KIT and protein kinase C-δ expression in adenoid cystic carcinoma: comparison with chromophobe renal cell carcinoma and gastrointestinal stromal tumour.
Park CK; Kim WK; Kim H
Histopathology; 2017 Oct; 71(4):529-542. PubMed ID: 28561935
[TBL] [Abstract][Full Text] [Related]
78. The GIST paradigm: how to establish diagnostic and prognostic criteria.
Calabuig-Farinas S; Lopez-Guerrero JA; Llombart-Bosch A
Arkh Patol; 2011; 73(4):13-21. PubMed ID: 22164425
[TBL] [Abstract][Full Text] [Related]
79. Abdominal monophasic synovial sarcoma is a morphological and immunohistochemical mimic of gastrointestinal stromal tumour.
Wong NA; Campbell F; Shepherd NA
Histopathology; 2015 Jun; 66(7):974-81. PubMed ID: 25346074
[TBL] [Abstract][Full Text] [Related]
80. Cathepsin L is highly expressed in gastrointestinal stromal tumors.
Miyamoto K; Iwadate M; Yanagisawa Y; Ito E; Imai J; Yamamoto M; Sawada N; Saito M; Suzuki S; Nakamura I; Ohki S; Saze Z; Kogure M; Gotoh M; Omicronbara K; Ohira H; Tasaki K; Abe M; Goshima N; Watanabe S; Waguri S; Takenoshita S
Int J Oncol; 2011 Nov; 39(5):1109-15. PubMed ID: 21769426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
